Table 3.
Total sample (n=7,810) | |||||
---|---|---|---|---|---|
Independent variables | Unadjusted | Adjusted for stage of COPD | |||
Adjusted R2 | 0.477 | 0.480 | |||
Unadjusted β (95% CI) | p | Adjusted β (95% CI) | p | ||
Clinical variables | FEV% of predicted value | −0.002 (−0.004, −0.001) | 0.001 | NS | |
Exacerbations during the past 12 months | 0.128 (0.105, 0.151) | <0.001 | 0.125 (0.102, 0.148) | <0.001 | |
Comorbidity | Depression/anxiety | 0.202 (0.113, 0.291) | <0.001 | 0.207 (0.118, 0.295) | <0.001 |
Patient-reported variables | Exercise capacity, days per week | −0.039 (−0.051, −0.027) | <0.001 | −0.039 (−0.051, −0.027) | <0.001 |
Functional dyspnoea (MRC) | 0.541 (0.512, 0.570) | <0.001 | 0.530 (0.500, 0.560) | <0.001 |